Results of Biocor stentless valve replacement for infective endocarditis of the native aortic valve.
The mid-term results in a selected group of 9 patients with native aortic valve endocarditis managed by aortic valve replacement (with or without complex annular reconstruction) using a totally biological stentless valve are outlined. At a mean follow-up of 48 months, there are currently 7 survivors (2 late noncardiac deaths) with 100% freedom from reoperation, valve-related complication, and endocarditis.
Santini
F
F
Department of Cardiovascular Surgery, University of Verona Medical School, Italy.
Bertolini
P
P
Vecchi
B
B
Borghetti
V
V
Mazzucco
A
A
D000328:Adult; D000368:Aged; D001705:Bioprosthesis; D004697:Endocarditis, Bacterial / Q000601:surgery*; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D012189:Retrospective Studies; D013536:Suture Techniques; D016896:Treatment Outcome